Advertisement

Topics

Companies Related to "Vaccination for Patients With High Risk Cancers of the Blood" [Most Relevant Company Matches] RSS

04:17 EST 10th December 2018 | BioPortfolio

Here are the most relevant search results for "Vaccination for Patients With High Risk Cancers of the Blood" found in our extensive corporate database of over 50,000 company records.

Showing "Vaccination Patients With High Risk Cancers Blood" Companies 1–25 of 8,900+

Relevant

Cervical Cancer-Free America

Cervical cancer is caused by persistent infections with high-risk types of the human papillomavirus (HPV). HPV is a very common sexually transmitted infection that 3 of 4 adults will have at some time in their lives. HPV vaccines are now available and target the two types of HPV that are responsible for 70 percent of all cervical cancers and are FDA-approved for girls and young women up to age 26....


Oncimmune (USA) LLC

Oncimmune's EarlyCDT-Lung test uses a panel of tumor antigens to detect the presence of immuno-biomarkers produced in the form of autoantibodies by the patient's immune system. Elevation of any one of six immuno-biomarkers (autoantibodies) above a predetermined cutoff value suggests that a tumor might be present. This simple blood test aids in risk assessment and the early detection of lung cancer...

Oncimmune LLC

Oncimmune's EarlyCDT-Lung test uses a panel of tumor antigens to detect the presence of immuno-biomarkers produced in the form of autoantibodies by the patient's immune system. Elevation of any one of six immuno-biomarkers (autoantibodies) above a predetermined cutoff value suggests that a tumor might be present. This simple blood test aids in risk assessment and the early detection of lung cancer...


Kepivance™ (palifermin)

Kepivance™ (palifermin) is indicated to decrease the incidence and duration of severe oral mucositis (mouth sores) in patients withhematologic (blood) cancers undergoing high-dose chemotherapy, with or without radiation, followed by bone marrow transplant. The safety and efficacy of Kepivance™ have not been established in patients with nonhematologic malignancies.

Kiadis Pharma N.V.

Kiadis Pharma is a clinical stage biopharmaceutical company focused on research, development and future commercialization of cell-based immunotherapy products for the treatment of blood cancers and inherited blood disorders. The Company believes that its innovative products have the potential to address the current risks and limitations connected with allo...

National Blood Clot Alliance

Interactive educational event for patients and families. Learn about the signs and how to reduce your risk for a blood clot

Be The Match

For people with life-threatening blood cancers—like leukemia and lymphoma—or other diseases, a cure exists. Be The Match connects patients with their donor match for a life-saving marrow or umbilical cord blood transplant. People can contribute to the cure as a member of the Be The Match Registry, financial contributor or volunteer. Be The Match ...

Finnish Red Cross Blood Service

The Finnish Red Cross Blood Service is the nationwide blood service provider in Finland. The Blood Service collects blood and processes it into such preparations and medicinal products as hospitals require for treating patients. The Blood Service is a financially and operationally independent section of the Finnish Red Cross. Each year 300 000 bags of blood are donated in Finland, with up to 60 00...

Kiadis B.V

“Kiadis : Your partner for discovery of novel high value compounds”. Kiadis is a drug disKiadis Pharma is an oncology company focused specifically on complications and limitations of bone marrow transplantations in blood cancer patients. The company has three blood cancer products in different phases of clinical development that offer novel treatment options for terminally ill cancer patients...

Pervasis Therapeutics, Inc.

More than eight million Americans over the age of 50 have peripheral arterial disease (PAD), a serious condition in which plaque builds up in arteries, restricting blood flow. PAD has significant health implications, including high blood pressure, reduced ability to walk, leg pain, and increased risk for heart attack and stroke.

Aviir Inc.

Aviir was founded in 2005 by cardiologists and scientists from the Stanford University School of Medicine to focus on discovery, development and commercialization of innovative diagnostic tests. The biotechnology company specializes in developing proprietary diagnostic tests that will assist in identifying patients that are truly at high risk for the...

Critical Diagnostics

Critical Diagnostics (www.criticaldiagnostics.com) develops products to help physicians optimize patient care in cardiovascular diseases, such as heart failure. Our high sensitivity Presage® ST2 Assay measures the level of ST2 in blood, identifying patients at increased risk of morbidity and mortality.

Replicon Technologies Incorporated

Replicon Technologies, Inc. (RTI) is an emerging biotechnology company focused on the use of replicons, non-replicating RNA viral particles, for the treatment of patients with cancer. RTI is founded on research and development performed at the University of Alabama at Birmingham (UAB), and supported by competitive grants from the National Institutes of Health, the Department of Defense, and SBIR ...

Memgen

Memgen is a clinical stage biotechnology company headquartered in Dallas, Texas, that is dedicated to developing therapies that improve overall survival in patients with blood and solid tumor cancers.

MetaStat, Inc.

MetaStat, Inc (OTCQB:MTST) is a molecular diagnostic company that develops and commercializes diagnostic tests for early and reliable prediction of systemic metastasis, the process by which cancer spreads from a primary tumor through the bloodstream to other areas of the body. MetaStat is focused on breast, prostate, lung and colorectal cancers, where syst...

Sarah Cannon Blood Cancer Network

The Sarah Cannon Blood Cancer Network is one of the largest providers of blood cancer care including blood and marrow transplantation (BMT) across the United States and United Kingdom. Its network conducts over 850 transplants annually and has treated more than 9,500 patients since the inception of our first program. Through its commitment to the highest l...

Haemonetics

For more than 30 years, Haemonetics has been a global leader in blood processing technology. The Company has two families of products:Donor Products - These products are marketed to the blood donation industry and include products that automate the blood donation process, automate the processing of blood, support pathogen inactivation and bacterial detection of blood, and test blood hematocrit.Pat...

AspenBio Pharma, Inc.

AspenBio Pharma, Inc. is an emerging in vitro diagnostic company focused on obtaining FDA clearance for its lead product, AppyScore, which is a unique blood-based test in development designed to help physicians manage the large number of patients who enter emergency rooms every year complaining of abdominal pain, many suspected of having acute appendicitis...

Life clinic Health Management Systems

Many medical conditions, such as high blood pressure, can be positively affected by lifestyle and the close monitoring of changes in vital signs. Working with our medical advisors, we have developed lifeclinic.com, a web site that can empower you to better manage your own health conditions. Not only will you be able to access information about the medical conditions you have, but you will also be ...

Summex Health Management

Summex is a national provider of health management services for large-scale employers. Our wellness programs are proven proactive tools that:Help employees avoid preventable illnesses & measurably improve their health Increase worksite productivity & reduce absenteeism Tangibly reduce health care costsSummex helps businesses by developing, implementing and managing comprehensive wellness programs ...

Priska

Priska™ is designed to provide assessment data associated with a patient’s risk for opioid abuse, as well as other mental health conditions. The Opioid Risk Tool assessment consists of a 5-question survey and fits each patient into one of three risk categories: low risk, moderate risk or high risk. The peer-reviewed tool is highly trusted and wid...

BioTime Incorporated

BioTime, Inc. (OTCBB: BTIM), based in Emeryville, California, is engaged in the research and development of aqueous-based synthetic solutions that may be used as plasma expanders, organ preservation solutions, or solutions to replace blood volume during low temperature surgery. These products are intended for several important medical applications including: the treatment of hypovolemia caused ...

diaDexus, Inc.

Founded in 1997 by SmithKline Beecham (now GlaxoSmithKline) and Incyte, diaDexus, Inc. is a privately held biotechnology company focused on discovering, developing, and commercializing novel, patent-protected diagnostic products with high clinical value.In June 2005, the FDA cleared the PLAC test as the first blood test for determining the risk for ischemic stroke associated with atherosclerosis. ...

Castle Biosciences Inc.

Castle Biosciences is a molecular diagnostics and prognostics company dedicated to helping patients and physicians make optimal decisions regarding treatment and follow-up care based on the tumor’s unique molecular signature. The Company currently offers prognostic tests for patients with rare cancers including uveal and cutaneous melanoma, esophageal...

The Lipoprotein(a) Foundation

Because approximately 63 million Americans have high Lipoprotein(a) and are at risk of premature cardiovascular disease, the vision for the foundation is: To live in a world where high Lipoprotein(a) is routinely diagnosed, treated and family screened. The mission is to prevent cardiovascular events due to high Lipoprotein(a) by diagnosing this inherited r...


More From BioPortfolio on "Vaccination for Patients With High Risk Cancers of the Blood"

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks